findmyKOL
Clinical trialNCT04466865CompletedInterventional

A Communication Tool to Assist Older Adults Facing Dialysis Choices

SponsorUniversity of Wisconsin, MadisonEnrollment407CommunicationDecision AidDecision MakingDecision Support TechniquesDialysisEnd of Life+8 more conditions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to test the effect of the "Best Case/Worse Case" (BC/WC) communication tool on receipt of palliative care and intensity of treatment at the end of life, quality of life, and quality of communication for older patients with end-stage renal disease (ESRD) receiving outpatient care at ten nephrology clinics. The intervention was developed and tested with acute care surgical patients at the University of Wisconsin (UW) and is now being testing to see if the intervention will work in a different setting. The intervention will be tested with 320 older adults who have end-stage renal disease (ESRD) and are receiving care from a nephrologist enrolled in the study. Randomly assigned nephrologists within each site will receive the intervention (training to use the BC/WC tool) or to be in the waitlist control, meaning that they will not be offered BC/WC training until the end of the study, when all participants have been enrolled. Participants will be on follow up with surveys and chart review for up to two years after study enrollment. Caregivers will also be invited to participate and complete surveys.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Colorado, Denver

    Denver, Colorado, United States

  • Northwestern University

    Chicago, Illinois, United States

  • Johns Hopkins University

    Baltimore, Maryland, United States

  • University of Michigan

    Ann Arbor, Michigan, United States

  • Columbia University

    New York, New York, United States

  • Mount Sinai School of Medicine

    New York, New York, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, United States

  • Department of Medicine, University of Vermont

    Burlington, Vermont, United States

  • University of Washington

    Seattle, Washington, United States

  • West Virginia University

    Morgantown, West Virginia, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Nov 2020
Primary completion
10 Nov 2025
Completion
28 Feb 2026
Last update posted
30 Apr 2026
Registered enrollment
407
Registry id
NCT04466865

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.